SXTP 60 DEGREES PHARMACEUTICALS, INC.: institutional ownership and insider trading
8 funds reported holding $668K of 60 DEGREES PHARMACEUTICALS, INC. in their latest 13F filings; in Q2 2026 funds net bought $273K, with 3 new positions and 3 funds selling out; over the last 12 months insiders bought $30.1K and sold $0 on the open market; over its last four quarters it reported revenue of $1.11M and net income of −$8.11M.
SXTP revenue and earnings
- Quarter ended Jun 30, 2026: revenue $208K, net income −$2.26M, EPS -0.90
- Quarter ended Mar 31, 2026: revenue $162K, net income −$2.09M, EPS -1.28
- Quarter ended Dec 31, 2025: revenue $303K, net income −$1.44M, EPS 0.19
- Quarter ended Sep 30, 2025: revenue $438K, net income −$2.32M, EPS -0.66
Famous investors holding SXTP
- Ken Griffin (Citadel Advisors): $39.4K, 0.0% of the portfolio
Largest institutional holders of SXTP
- Kathmere Capital Management, LLC — $520K
- CITADEL ADVISORS LLC — $39.4K
- XTX Topco Ltd — $31.0K
- Kovack Advisors, Inc. — $26.4K
- GEODE CAPITAL MANAGEMENT, LLC — $25.6K
- UBS Group AG (UBS) — $23.9K
- BARCLAYS PLC (BCS, BCLYF) — $1.85K
- OSAIC HOLDINGS, INC. — $44
Recent SXTP insider trades
- Jun 12, 2026: Dow Geoffrey S bought 7,350 shares ($10.1K)
- Dec 15, 2025: Dow Geoffrey S bought 9,670 shares ($7.74K)
- Dec 11, 2025: Dow Geoffrey S bought 12,963 shares ($12.2K)
- Jun 3, 2025: Xu Cheryl bought 5,000 shares ($14.4K)
5%+ owners
- Mitchell P. Kopin: 9.1% (Schedule 13G/A, filed May 13, 2026)
- CVI Investments, Inc.: 7.0% (Schedule 13G/A, filed May 15, 2026)
- Lind Global Fund III LP: 5.5% (Schedule 13G, filed Aug 5, 2026)
Who owns the most SXTP stock?
The largest institutional holders of 60 DEGREES PHARMACEUTICALS, INC. in the latest 13F filings are Kathmere Capital Management, LLC ($520K), CITADEL ADVISORS LLC ($39.4K), XTX Topco Ltd ($31.0K).
Are insiders buying or selling SXTP?
Over the last 12 months insiders bought $30.1K and sold $0 of 60 DEGREES PHARMACEUTICALS, INC. stock on the open market (SEC Form 4).
Which famous investors own SXTP?
Ken Griffin.
What was SXTP's revenue last quarter?
60 DEGREES PHARMACEUTICALS, INC. reported revenue of $208K for the quarter ended June 30, 2026, with net income of −$2.26M.